Overcoming target interference in bridging anti-drug antibody (ADA) assay by optimizing sample treatment

Compared to previously reported methods for mitigating target interference, the acid panel treatment approach is simpler, more time-efficient, and cost-effective. This user-friendly strategy can be readily applied to eliminate soluble dimeric targets during ADA method development, particularly in cases where alternative methodologies are not feasible or applicable.